Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $728.29 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $315.02 | 3 | $0 (2024) |
| Global Blood Therapeutics, Inc. | $121.83 | 1 | $0 (2022) |
| Novo Nordisk Inc | $121.35 | 1 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $97.02 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $73.07 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $280.78 | 3 | Novo Nordisk Inc ($121.35) |
| 2023 | $107.10 | 1 | Teva Pharmaceuticals USA, Inc. ($107.10) |
| 2022 | $340.41 | 3 | Global Blood Therapeutics, Inc. ($121.83) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.35 | General |
| Category: Obesity | ||||||
| 04/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $86.36 | General |
| Category: Central Nervous System | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $73.07 | General |
| Category: Respiratory | ||||||
| 09/27/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $107.10 | General |
| Category: Neurology | ||||||
| 10/26/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $121.56 | General |
| Category: Central Nervous System | ||||||
| 09/28/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Sickle Cell Disease | ||||||
| 06/23/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $97.02 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 425 | 808 | $282,540 | $47,825 |
| 2022 | 2 | 341 | 634 | $222,420 | $39,143 |
| 2021 | 3 | 763 | 1,297 | $447,307 | $82,048 |
| 2020 | 2 | 542 | 905 | $312,900 | $57,604 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 295 | 669 | $240,840 | $35,846 | 14.9% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 130 | 139 | $41,700 | $11,979 | 28.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 244 | 537 | $193,320 | $30,340 | 15.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 97 | 97 | $29,100 | $8,803 | 30.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 491 | 1,017 | $365,400 | $57,185 | 15.6% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2021 | 250 | 257 | $77,100 | $23,276 | 30.2% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2021 | 22 | 23 | $4,807 | $1,587 | 33.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 356 | 685 | $246,600 | $38,702 | 15.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2020 | 186 | 220 | $66,300 | $18,902 | 28.5% |
About Dr. Wael Sakr, MD
Dr. Wael Sakr, MD is a Anatomic Pathology healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033156633.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wael Sakr, MD has received a total of $728.29 in payments from pharmaceutical and medical device companies, with $280.78 received in 2024. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($728.29).
As a Medicare-enrolled provider, Sakr has provided services to 2,071 Medicare beneficiaries, totaling 3,644 services with total Medicare billing of $226,621. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location Detroit, MI
- Active Since 06/01/2006
- Last Updated 09/21/2016
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1033156633
Products in Payments
- OXBRYTA (Drug) $121.83
- AUSTEDO (Drug) $121.56
- Wegovy (Drug) $121.35
- UZEDY (Drug) $107.10
- Kerendia (Drug) $97.02
- Austedo XR (Drug) $86.36
- TEZSPIRE (Biological) $73.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Detroit
Christian Keller, M.d, M.D
Anatomic Pathology — Payments: $3,018
Fulvio Lonardo, Md, MD
Anatomic Pathology
Basim Al-Khafaji, Md, MD
Anatomic Pathology
Frederick Meier, M.d, M.D
Anatomic Pathology
Adrian Ormsby, M.d, M.D
Anatomic Pathology
Ather Naseemuddin, M.d, M.D
Anatomic Pathology